Seroquel XR Bipolar

Links shared publicly online about this topic

Seroquel XR

schizophrenia.emedtv.com — “Seroquel XR is an antipsychotic medication that is used to treat schizophrenia and bipolar disorder. This eMedTV article takes a look at the prescription medication, providing information on its uses, dosing guidelines, possible side effects, and more.View full resource at schizophrenia.emedtv.com

  • View Related
  • Share

Most Recently Shared on May 27, 2011 at 12:43 am By:

MentalHealth_OW Mental Health OW OW Health

Why Consider Seroquel XR to Treat Bipolar Disorder http://bit.ly/iGTIVd

1 year ago...

RxEconsult, LLC - Seroquel XR for schizophrenia, bipolar disorder, and depression

rxeconsult.com — “RxEconsult, LLC - Seroquel XR for schizophrenia, bipolar disorder, and depressionView full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on October 23, 2011 at 12:57 am By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

New article: #Seroquel XR for #depression, #bipolar disorder, and #schizophrenia http://t.co/k513ocPT #health #Medications

7 months ago...

How does Seroquel XR treat bipolar disorder? - Sharecare

sharecare.com — “Alone, Seroquel XR treats short-term symptoms of bipolar disorder. With other medications, it can be a long-term maintenance protocol. Find out more.View full resource at sharecare.com

  • View Related
  • Share

Most Recently Shared on May 27, 2011 at 12:43 am By:

MentalHealth_OW Mental Health OW OW Health

How does Seroquel XR treat bipolar disorder? http://bit.ly/jqdEXQ

1 year ago...

Study: Seroquel XR May Help Treat Generalized Anxiety Disorder

webmd.com — “Seroquel XR, an antipsychotic drug approved to treat schizophrenia and bipolar disorder, may ease generalized anxiety disorder, new research shows.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on September 4, 2008 at 4:27 pm By:

WebMD_News WebMD_News Health News

WebMD Health News Antipsychotic Drug May Ease Anxiety: Seroquel XR, an antipsychotic .. http://tinyurl.com/6dnyul

4 years ago...

FDA Approves Seroquel XR For Add-On Treatment of Major Depressive Disorder

drugs.com — “Seroquel XR (quetiapine) is used as an adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD). Includes Seroquel XR side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 7, 2009 at 11:13 pm By:

drugscom Drugs.com Health Site

FDA Approves Seroquel XR For Add-On Treatment of Major Depressive Disorder - http://bit.ly/8XKlvN

2 years ago...

SEROQUEL EU Approval for Bipolar Maintenance

astrazeneca.com — “SEROQUEL EU Approval for Bipolar MaintenanceView full resource at astrazeneca.com

  • View Related
  • Share

Most Recently Shared on September 29, 2009 at 8:44 am By:

whydotpharma Silja Health Social Media

RT @msinned: AZ's Seroquel XR & Seroquel approved in EU for prevention of recurrence of bipolar disorder http://bit.ly/qtzFQ #hcsmeu

3 years ago...

Intellipharmaceutics seeks to market generic Seroquel XR | Drug Store News

drugstorenews.com — “Intellipharmaceutics seeks to market generic Seroquel XR | Drug Store NewsView full resource at drugstorenews.com

  • View Related
  • Share

Most Recently Shared on April 6, 2011 at 1:37 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Intellipharmaceutics seeks to market generic Seroquel XR http://bit.ly/i1SmWX #bipolar

1 year ago...

Intellipharmaceutics Files ANDA With FDA For Generic Seroquel XR - Quick Facts

rttnews.com — “IntelliPharmaCeutics International Inc. (IPCI) announced the filing of an Abbreviated New Drug Application or ANDA with the U.S. Food and Drug Administration or FDA for a generic of Seroquel XR.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 10:56 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Intellipharmaceutics Files ANDA With FDA For Generic Seroquel XR - Quick Facts http://bit.ly/hCMUJE #bipolar

1 year ago...

Article > Europe says yes to AstraZeneca's Seroquel XR

pharmatimes.com — “Article > Europe says yes to AstraZeneca's Seroquel XRView full resource at pharmatimes.com

  • View Related
  • Share

Most Recently Shared on September 2, 2010 at 12:21 pm By:

Astra receives EU approval for Seroquel XR - BusinessWeek

businessweek.com — “AstraZeneca PLC says the European Union has approved its Seroquel XR tablets as an add-on treatment for major depressive episodes in patients who have not responded well to other antidepressants.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on September 2, 2010 at 5:15 pm By:

AstraZeneca announces SEROQUEL XR is now available to treat bipolar depression

astrazeneca-us.com — “Learn about SEROQUEL XR and how it is now approved to treat the depressive, manic, and mixed episodes of bipolar disorder.View full resource at astrazeneca-us.com

  • View Related
  • Share

Most Recently Shared on February 23, 2009 at 5:08 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

AstraZeneca announces SEROQUEL XR is now available to treat bipolar depression http://is.gd/kyIQ

3 years ago...

US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder

medicalnewstoday.com — “Astrazeneca (nyse: azn) announced that the us food and drug administration (fda) has approved once-daily seroquel xr® (quetiapine fumarate) extended release tablets as adjunctive (add-on) treView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 5, 2009 at 12:19 pm By:

mnt_depression MNT Depression News Health News

US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder: AstraZeneca (NYSE: AZN) annou.. http://bit.ly/7L8u0I

2 years ago...

AstraZeneca's Seroquel XR receives EC approval as an add-on treatment for major depressive disorder - International

pharmabiz.com — “AstraZeneca announced that the European Commission (EC) has issued a positive decision for the approval of once-daily Seroquel XR (quetiapine fumarate) extended release tablets as an add-on treatmentView full resource at pharmabiz.com

  • View Related
  • Share

Most Recently Shared on September 3, 2010 at 5:58 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

AstraZeneca's Seroquel XR receives EC approval as an add-on treatment of major ... http://bit.ly/dDdf0f #bipolar

2 years ago...

Seroquel XR approved for adjunctive treatment of major depressive disorder (MDD) - MPR

empr.com — “Seroquel XR (quetiapine fumarate extended-release tablets, from AstraZeneca) has been approved by the FDA as adjunctive treatment to antidepressants in adults with major depressive disorder (MDD).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on December 7, 2009 at 4:43 pm By:

eMPR MPR Medical Publisher

MPR News: Seroquel XR approved for adjunctive treatment of major depressive disorder (MDD): Seroquel XR (quetiapine... http://bit.ly/8tfaNR

2 years ago...

High Court rules against Seroquel XR patent | InPharm

inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.View full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 10:14 am By:

Pharmafocus Pharmafocus Health News and Pharma

High Court rules against Seroquel XR patent - http://t.co/3gEMvnVt

2 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MentalHealth_OW

    Mental Health OW

    Organizing mental health and addiction resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

    Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." />

    Ome Ogbru, PharmD

    Dr. Ome Ogbru is the founder of RxEconsult, which is a social network for healthcare consulting, healthcare jobs, healthcare professionals, healthcare small businesses, life scientists, health information, and more. Members have profiles with details about their services on RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

    Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication.

    View Profile

  • MentalHealth_OW

    Mental Health OW

    Organizing mental health and addiction resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390